Search Tag: naltrexone-bupropion

Cardiology Management

Cardiovascular Safety of Obesity Drugs

2016 08 Mar

According to a study published in JAMA, the cardiovascular safety of obesity drug combination naltrexone-bupropion is uncertain especially in light of the unanticipated early termination of a clinical trial to determine its safety. To date, drugs that have been used to treat obesity have only provided mixed results and modest weight loss. No significant... Read more

Endorsed Companies